近来尽管发展了胎脑移植、多巴胺受体激动剂等治疗帕金森病,然而L-多巴和多巴胺脱羧酶抑制剂的复方品仍然是不可替代的药品。国产森纳梅脱就是其中之一。我们采用丽珠集团利民制药厂研制的森纳梅脱治疗帕金森病,现报告如下: 方法 1.病例选择:森纳梅脱共治疗100例原发性帕金森病(男性64例,女性36例),平均年龄59.6±9.9岁。对照组60例(男性33 Although the development of fetal brain transplantation, dopamine receptor agonists and other treatment of Parkinson’s disease recently, however, L-dopa and dopamine decarboxylase inhibitor compound is still an irreplaceable drug. Domestic Senna plum is one of them. We use the Sennheiser off the Parkinson’s disease developed by Livzon Pharmaceutical Group Limin Pharmaceutical Factory, are reported as follows: Method 1. Case Selection: Sennomer off 100 cases of primary Parkinson’s disease (male 64, female 36 cases), with an average age of 59.6 ± 9.9 years. Control group of 60 patients (33 males